Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc S Ernstoff

Showing results (61-70 of 169) with videos related to

Pageof 17
Sort By:
Cancer Medicine|May 6, 2023
A phase II study of alternating sunitinib and temsirolimus therapy in patients with metastatic renal cell carcinomaDylan B Ness, Darcy B Pooler, Steven Ades, et al.
Frontiers in Oncology|May 17, 2021
Case Report: Immune Checkpoint Inhibitor-Induced Exuberant Tumor Inflammation With Accelerated Clinical Deterioration in Metastatic Renal Cell CarcinomaDharmesh Gopalakrishnan, Rohit K Jain, Laurie Herbst, et al.
Cancer Research|April 3, 2014
VISTA is an immune checkpoint molecule for human T cellsJ Louise Lines, Eirini Pantazi, Justin Mak, et al.
Immunological Investigations|August 18, 2020
An Immunosuppressive Effect of Melanoma-derived Exosomes on NY-ESO-1 Antigen-specific Human CD8<sup>+</sup> T Cells is Dependent on IL-10 and Independent of BRAF<sup>V600E</sup> Mutation in Melanoma Cell LinesShinLa Shu, Junko Matsuzaki, Muzamil Y Want, et al.
The Journal of Clinical Investigation|May 5, 2011
Autoimmune melanocyte destruction is required for robust CD8+ memory T cell responses to mouse melanomaKatelyn T Byrne, Anik L Côté, Peisheng Zhang, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 2, 2007
Report on the ISBTC mini-symposium on biologic effects of targeted therapeuticsMichael B Atkins, David Carbone, George Coukos, et al.
Future Oncology (London, England)|August 25, 2017
Challenges faced when identifying patients for combination immunotherapyMarc S Ernstoff, Shipra Gandhi, Manu Pandey, et al.
Journal of Neuro-Oncology|October 15, 2021
Systemic coagulation is activated in patients with meningioma and glioblastomaSwaroopa Yerrabothala, Brett L Gourley, James C Ford, et al.
International Journal of Psychiatry in Medicine|June 22, 2002
Expressive disclosure and health outcomes in a prostate cancer populationHarriet J Rosenberg, Stanley D Rosenberg, Marc S Ernstoff, et al.
The American Journal of Surgical Pathology|May 16, 2019
Small and Isolated Immunohistochemistry-positive Cells in Melanoma Sentinel Lymph Nodes Are Associated With Disease-specific and Recurrence-free Survival Comparable to that of Sentinel Lymph Nodes Negative for MelanomaRobert E LeBlanc, Dorothea T Barton, Zhongze Li, et al.
Pageof 17

Showing results (61-70 of 169) with videos related to

Sort By:
Pageof 17
Cancer Medicine|May 6, 2023
A phase II study of alternating sunitinib and temsirolimus therapy in patients with metastatic renal cell carcinomaDylan B Ness, Darcy B Pooler, Steven Ades, et al.
Frontiers in Oncology|May 17, 2021
Case Report: Immune Checkpoint Inhibitor-Induced Exuberant Tumor Inflammation With Accelerated Clinical Deterioration in Metastatic Renal Cell CarcinomaDharmesh Gopalakrishnan, Rohit K Jain, Laurie Herbst, et al.
Cancer Research|April 3, 2014
VISTA is an immune checkpoint molecule for human T cellsJ Louise Lines, Eirini Pantazi, Justin Mak, et al.
Immunological Investigations|August 18, 2020
An Immunosuppressive Effect of Melanoma-derived Exosomes on NY-ESO-1 Antigen-specific Human CD8<sup>+</sup> T Cells is Dependent on IL-10 and Independent of BRAF<sup>V600E</sup> Mutation in Melanoma Cell LinesShinLa Shu, Junko Matsuzaki, Muzamil Y Want, et al.
The Journal of Clinical Investigation|May 5, 2011
Autoimmune melanocyte destruction is required for robust CD8+ memory T cell responses to mouse melanomaKatelyn T Byrne, Anik L Côté, Peisheng Zhang, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 2, 2007
Report on the ISBTC mini-symposium on biologic effects of targeted therapeuticsMichael B Atkins, David Carbone, George Coukos, et al.
Future Oncology (London, England)|August 25, 2017
Challenges faced when identifying patients for combination immunotherapyMarc S Ernstoff, Shipra Gandhi, Manu Pandey, et al.
Journal of Neuro-Oncology|October 15, 2021
Systemic coagulation is activated in patients with meningioma and glioblastomaSwaroopa Yerrabothala, Brett L Gourley, James C Ford, et al.
International Journal of Psychiatry in Medicine|June 22, 2002
Expressive disclosure and health outcomes in a prostate cancer populationHarriet J Rosenberg, Stanley D Rosenberg, Marc S Ernstoff, et al.
The American Journal of Surgical Pathology|May 16, 2019
Small and Isolated Immunohistochemistry-positive Cells in Melanoma Sentinel Lymph Nodes Are Associated With Disease-specific and Recurrence-free Survival Comparable to that of Sentinel Lymph Nodes Negative for MelanomaRobert E LeBlanc, Dorothea T Barton, Zhongze Li, et al.
Pageof 17